China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A retrospective study on the role and mechanism of Epstein-Barr virus protein BRRF2 in inhibiting innate immunity through exosomes'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129636
Registration Time: 2026/08/07
Type: Observational study
Primary Sponsor: Sun Yat-sen University Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=307223
Published by HT Digital Content Services with permission from Health Daily Digest....